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and dark skin showed that the same X chromosome was active in both sites, rather than the normal paternal X in the normal skin and the abnormal maternal X in the pigmented skin as had been expected. This result was attributed to the proliferative advantage of cells containing the normal X."7 Most recently it has been tested in patients with chromosomal mosaicism and linear dyspigmentation. There are now many reports of cytogenetic studies on fibroblasts cultured from light and dark skin, but hardly any show pure cultures of the two different cell lines in the two different biopsies: there is almost always a mixture in one or both biopsies. [11] [12] [13] [14] [15] The most likely explanation for this is that fibroblasts do not conform to Blaschko's lines.
Most of the dermatoses following Blaschko's lines (table 1) affect ectodermal derivatives, namely melanocytes, keratinocytes, or epidermal appendages. Similarly all the chimeric animal studies involve epidermal cells.4 5 Therefore, we performed cytogenetic studies on cultured epidermal cells from light and dark areas of four patients with linear dyspigmentation, three of whom had severe neurological deficit (HI). We chose to examine keratinocytes rather than melanocytes simply because they are easier to grow.
Methods CELL CULTURE AND CHROMOSOME ANALYSIS
Metaphase chromosome preparations were made from peripheral blood lymphocytes and cultured skin fibroblasts using standard methods.
For the preparation of keratinocytes for chromosome analysis the skin biopsies were washed in calcium and magnesium free PBS and then floated in 2 ml 0 1% trypsin solution for one hour at 37°C with agitation at 10 minute intervals, to separate the epidermis. The epidermis was then peeled back and the keratinocytes gently scraped from the keratin layer, and from the epidermal side of the basement membrane. The loose cells were collected by washing the tissue with medium and centrifuging the resultant cell suspension.
The cell yield was placed in a 60 mm petri dish containing 5 x 105 feeder cells (Swiss 3T3.J2 irradiated mouse fibroblasts) and K medium18 without epidermal growth factor (EGF). Mouse EGF (1O ng/ml) was added at the first medium change (three to four days) and at all subsequent changes. Cultures were incubated at 37°C in 10% CO2 in air.
Primary cultures were subcultured after eight days' growth. The feeder layers were selectively removed by vigorous pipetting with 0-01% EDTA before disaggregating the keratinocytes with 1 part trypsin:1 part EDTA. Secondary cultures were established at 105 cells per 25 cm2 growth area flasks prepared as for primary culture. Before harvesting for cytogenetics the feeder cells were again removed and metaphases prepared using standard methods.
PATIENTS
Case 1, an Asian female aged 3 years, had facial asymmetry, developmental delay, bilateral sensorineural deafness, and hypopigmented streaks and whorls (fig 1) . Previous group.bmj.com on January 6, 2016 -Published by http://jmg.bmj.com/ Downloaded from not yet been tested. Interestingly, case 3 was the most mildly affected neurologically of the patients we studied. Embryologically, keratinocytes and the central nervous system have the same ectodermal origin, while melanocytes derive later from the neural crest. We suggest that in this patient the abnormal cell line developed in the mesoderm and neural crest, largely sparing the keratinocytes and brain. We plan to test this hypothesis in future by examining cultured melanocytes for mosaicism.
(3) We predicted that in subjects with epidermal mosaicism, one skin type would show one cell line and the other skin type would show the other cell line. Our results have indeed shown this in case 1 and also in case 2 with the exception of only one cell.
(4) In both patients showing epidermal mosaicism, the abnormal (pale) skin contained the abnormal cell line. This revives the possibility that the cytogenetic abnormality is directly responsible for the failure of pigmentation. Previous studies in fibroblasts have shown abnormal cells in both light and dark skin: this observation, and the fact that so many different cytogenetic abnormalities produce the same appearance, has led to the idea that the pigmentary anomaly is a non-specific result of genetically different cells migrating together.23 However, this does not explain the fact that most chromosomally mosaic patients do not have linear dyspigmentation. Furthermore, the control of pigment production, storage, and distribution is controlled by many genes,24 and could probably be disturbed by many different chromosomal rearrangements in keratinocytes or melanocytes.
In conclusion, our limited findings support the idea that Blaschko's lines are determined by epidermal rather than fibroblast clones. We suggest that looking for chromosomal mosaicism is a more sensitive test for HI when carried out in keratinocytes rather than in fibroblasts alone, and in future melanocytes should also be studied. The presence of mosaicism in fibroblasts but not keratinocytes might be associated with a better prognosis neurologically. Finally, the cytogenetic abnormality in the epidermis might be directly responsible for the failure of pigmentation in the pale streaks of hypomelanosis of Ito.
